Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.34% vs 29.76% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 73.09% vs 9.20% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 134.42% vs -2.15% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 76.78% vs 4.30% in Mar 2025
Compare Profit and Loss Results of Aristo Bio-Tech
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
363.00
141.00
222.00
157.45%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
363.00
141.00
222.00
157.45%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-3.00
2.00
66.67%
Raw Materials Consumed
332.00
124.00
208.00
167.74%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
4.00
1.00
3.00
300.00%
Operating Expenses
7.00
4.00
3.00
75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
347.00
130.00
217.00
166.92%
Operating Profit (PBDIT) excl Other Income
16.00
10.00
6.00
60.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
16.00
12.00
4.00
33.33%
Interest
3.00
2.00
1.00
50.00%
Profit before Depriciation and Tax
12.00
9.00
3.00
33.33%
Depreciation
2.00
2.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
9.00
7.00
2.00
28.57%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
7.00
2.00
28.57%
Provision for Tax
2.00
1.00
1.00
100.00%
Profit After Tax
7.00
5.00
2.00
40.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
3.00
17.00
566.67%
Profit Available for appropriations
27.00
9.00
18.00
200.00%
Appropriations
27.00
9.00
18.00
200.00%
Equity Dividend (%)
6%
0%
6.00
Earnings Per Share
10.55
2.3
8.25
358.70%
Profit And Loss - Net Sales
Net Sales 363.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.34% vs 29.76% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 73.09% vs 9.20% in Mar 2025
Profit And Loss - Interest
Interest 3.89 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 134.42% vs -2.15% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 7.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 76.78% vs 4.30% in Mar 2025
Footer loading
